help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NOGUERA, A.
Right arrow Articles by AGUSTÍ, A. G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NOGUERA, A.
Right arrow Articles by AGUSTÍ, A. G. N.

Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, 1664-1668

Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease

AINA NOGUERA, XAVIER BUSQUETS, JAUME SAULEDA, JOSE  M. VILLAVERDE, WILLIAM MacNEE, and ALVAR G. N. AGUSTÍ

Servei de Pneumologia, Servei de Analisis Cliniques, and Unitat d'Investigació (REUNI), Hospital Universitari Son Dureta, Palma de Mallorca, Spain; and Respiratory Medicine Unit, Department of Medicine, University of Edinburgh, Royal Infirmary, Edinburgh, United Kingdom

We investigated the expression of adhesion molecules in circulating neutrophils (lymphocyte function-associated antigen-1 [LFA-1], Mac-1, and L-selectin) and endothelial cells (soluble intercellular adhesion molecule-1[sICAM-1]) in 23 patients with stable chronic obstructive pulmonary disease (COPD), 18 subjects with exacerbated COPD, and 23 healthy volunteers. Also, in these circulating neutrophils, we assessed the expression of two G protein subunits (Galpha s and Galpha i1/2). Compared with control subjects, patients with stable COPD showed increased expression of Mac-1 (p < 0.001) and lower levels of sICAM-1 (p = 0.002); LFA-1 and L-selectin expression was similar in patients and control subjects. During exacerbations, compared with stable patients, the expression of Mac-1 and LFA-1 was reduced (p < 0.001). Finally, the expression of Galpha s (but not Galpha i1/2) was also reduced (p < 0.001) in circulating neutrophils of patients with COPD, irrespective of the clinical condition of the patient. These results indicate that in patients with COPD: (1) the expression of some neutrophil adhesion molecules (Mac-1) is abnormal, and that this pattern changes during exacerbations; (2) there may be a form of endothelial dysfunction, as suggested by the low sICAM-1 levels; (3) the expression of G protein subunit (Galpha s) in circulating neutrophils is downregulated, irrespective of their clinical conditions. Overall, these results indicate the presence of significant systemic abnormalities in COPD.




This article has been cited by other articles:


Home page
 ThoraxHome page
A Di Stefano, G Caramori, I Gnemmi, M Contoli, L Bristot, A Capelli, F L M Ricciardolo, F Magno, S E. D'Anna, A Zanini, et al.
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD
Thorax, November 1, 2009; 64(11): 968 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. T. McNicholas
Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: Overlaps in Pathophysiology, Systemic Inflammation, and Cardiovascular Disease
Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 692 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. MacNee, J. Maclay, and D. McAllister
Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Barbier, A. Agusti, and S. Alberti
Fluticasone propionate reduces bacterial airway epithelial invasion
Eur. Respir. J., November 1, 2008; 32(5): 1283 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS, October 1, 2007; 4(7): 522 - 525.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. Yamagata, H. Sugiura, T. Yokoyama, S. Yanagisawa, T. Ichikawa, K. Ueshima, K. Akamatsu, T. Hirano, M. Nakanishi, Y. Yamagata, et al.
Overexpression of CD-11b and CXCR1 on Circulating Neutrophils: Its Possible Role in COPD
Chest, September 1, 2007; 132(3): 890 - 899.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V. Pinto-Plata, J. Toso, K. Lee, D. Park, J. Bilello, H. Mullerova, M. M De Souza, R. Vessey, and B. Celli
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Thorax, July 1, 2007; 62(7): 595 - 601.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest, January 1, 2007; 131(1): 37 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
B. R. Celli
Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance
Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Rahman and I. M. Adcock
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur. Respir. J., July 1, 2006; 28(1): 219 - 242.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Palange, U. Testa, A. Huertas, L. Calabro, R. Antonucci, E. Petrucci, E. Pelosi, L. Pasquini, A. Satta, G. Morici, et al.
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD.
Eur. Respir. J., March 1, 2006; 27(3): 529 - 541.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V M Pinto-Plata, H Mullerova, J F Toso, M Feudjo-Tepie, J B Soriano, R S Vessey, and B R Celli
C-reactive protein in patients with COPD, control smokers and non-smokers
Thorax, January 1, 2006; 61(1): 23 - 28.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Wehlin, M. Lofdahl, J. Lundahl, and M. Skold
Reduced Intracellular Oxygen Radical Production in Whole Blood Leukocytes From COPD Patients and Asymptomatic Smokers
Chest, October 1, 2005; 128(4): 2051 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
P. J. Barnes
New approaches to COPD
Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Santus, A. Sola, P. Carlucci, F. Fumagalli, A. Di Gennaro, M. Mondoni, C. Carnini, S. Centanni, and A. Sala
Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 838 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Noguera, E. Sala, A. R. Pons, J. Iglesias, W. MacNee, and A. G.N. Agusti
Expression of Adhesion Molecules During Apoptosis of Circulating Neutrophils in COPD
Chest, May 1, 2004; 125(5): 1837 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.W. Boots, G.R.M.M. Haenen, and A. Bast
Oxidant metabolism in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 14s - 27s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Gabrijelcic, A. Acuna, M. Profita, A. Paterno, K.F. Chung, A.M. Vignola, and R. Rodriguez-Roisin
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Eur. Respir. J., August 1, 2003; 22(2): 290 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets
Systemic effects of chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2003; 21(2): 347 - 360.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E F M Wouters
Chronic obstructive pulmonary disease * 5: Systemic effects of COPD
Thorax, December 1, 2002; 57(12): 1067 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Kelly, M A Dentener, E C Creutzberg, and E F M Wouters
Pathophysiology of COPD
Thorax, June 1, 2002; 57(6): 563 - 564.
[Full Text] [PDF]

Home page
 ChestHome page
E. F. M. Wouters, E. C. Creutzberg, and A. M. W. J. Schols
Systemic Effects in COPD*
Chest, May 1, 2002; 121 (2009): 127S - 130S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. A. Stockley
Neutrophils and the Pathogenesis of COPD*
Chest, May 1, 2002; 121 (2009): 151S - 155S.
[Full Text] [PDF]

Home page
 ThoraxHome page
M A Dentener, E C Creutzberg, A M W J Schols, A Mantovani, C van`t Veer, W A Buurman, and E F M Wouters
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations
Thorax, September 1, 2001; 56(9): 721 - 726.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
G. Cella, A. Sbarai, G. Mazzaro, B. Vanzo, S. Romano, D. Hoppensteadt, and J. Fareed
Plasma Markers of Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 205 - 208.
[Abstract] [PDF]

Home page
 ThoraxHome page
A Noguera, S Batle, C Miralles, J Iglesias, X Busquets, W MacNee, and A G N Agustí
Enhanced neutrophil response in chronic obstructive pulmonary disease
Thorax, June 1, 2001; 56(6): 432 - 437.
[Abstract] [Full Text]

Home page
 FASEB J.Home page
S. CUZZOCREA, E. MAZZON, L. DUGO, I. SERRAINO, A. CICCOLO, T. CENTORRINO, A. DE SARRO, and A. P. CAPUTI
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat
FASEB J, May 1, 2001; 15(7): 1187 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L. Koenderman, D. Kanters, B. Maesen, J. Raaijmakers, J.-W. J. Lammers, J. de Kruif, and T. Logtenberg
Monitoring of neutrophil priming in whole blood by antibodies isolated from a synthetic phage antibody library
J. Leukoc. Biol., July 1, 2000; 68(1): 58 - 64.
[Abstract] [Full Text]

Home page
 ChestHome page
N. F. Voelkel and R. Tuder
COPD : Exacerbation
Chest, May 1, 2000; 117 (2009): 376S - 379S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. MacNee
Oxidants/Antioxidants and COPD
Chest, May 1, 2000; 117 (2009): 303S - 317S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. MACNEE and I. RAHMAN
Oxidants and Antioxidants as Therapeutic Targets in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S58 - 65.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society 		  ATS Coding and Billing Quarterly